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Synopsis
HF (heart failure) after MI (myocardial infarction) is a major cause of morbidity and mortality worldwide. Recent studies
have shown that hydrogen sulﬁde (H2S) has cardioprotective effects. Hence, we aimed to elucidate the potential
effects of H2S on HF after MI in rats. The HF model after MI was made by ligating the left anterior descending
coronary artery. HF groups and sham-operated groups of rats were treated with vehicle, sodium hydrosulﬁde (NaHS)
or PAG (propagylglycine). Equal volumes of saline, 3.136 mg · kg−1 · day−1 NaHS or 37.5 mg · kg−1 · day−1 PAG, were
intraperitoneally injected into rats for 6 weeks after operation. Survival, lung-to-body weight ratio and left ventricular
haemodynamic parameters were measured. The protein and gene expression of Bcl-2, Bax, caspase 3 and cytochrome
c were analysed by Western blotting and RT–PCR (reverse transcription–PCR). TUNEL (terminal deoxynucleotidyl
transferase-mediated dUTP nick-end labelling) and EM (electron microscopy) were used to examine apoptosis of heart
tissues. NaHS was found to improve the survival and lower the lung-to-body weight ratio. It increased the LVSP (left
ventricular systolic pressure) and the maximum rate of pressure and decreased LVEDP (left ventricular end-diastolic
pressure). Furthermore, NaHS promoted Bcl-2 protein and mRNA expression and demoted Bax, caspase 3 protein
and mRNA expression in HF rats. We also showed that NaHS decreased the leakage of cytochrome c protein from
the mitochondria to the cytoplasm. Histological observation by TUNEL and EM proved that NaHS inhibited cardiac
apoptosis in HF hearts and improved mitochondrial derangements, but that PAG aggravated those indices. Hence,
H2S has protective effects in HF rats.
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INTRODUCTION
HF (heart failure) is a major cause of morbidity and mortality
worldwide [1,2], and MI (myocardial infarction) is one of the
most common causes of HF [3]. Apoptosis of cardiac myocytes
isconsideredtobethemainreasonforHF.Inmanyheartdiseases
suchasMI,ischaemia/reperfusioninjuryorcardiomyopathy,car-
diacmyocyteapoptosismaybeinducedbymolecularstimulisuch
as reactive oxygen species, angiotensin II, β1-adrenergic agon-
ists, pro-inﬂammatory cytokines and stretch [4]. If these diseases
are not treated properly, heart function may be affected, eventu-
ally resulting in HF. Hence, interrupting the apoptosis of cardiac
myocytes may increase the survival rate, ameliorate the impact
of ventricular dysfunction and arrest the progression to HF. Hy-
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drogen sulﬁde (H2S), the third endogenous gaseous transmitter
in mammals besides nitric oxide (NO) and carbon monoxide
(CO), plays an important role in many organ systems [5–7]. In
the cardiovascular system, H2S is produced in the myocardium,
ﬁbroblasts and blood vessels from L-cysteine by the enzyme
CSE(cystathionineγ-lyase).Mostimportantly,H2Sexecutes the
physiological functions of vasorelaxation, cardioprotection [8,9]
andinhibitionofvascularremodelling.Itisalsobroughtintocon-
textwithavarietyofcardiovasculardiseasessuchasspontaneous
hypertension,hypoxia-inducedpulmonaryhypertensionandhigh
pulmonary blood ﬂow-induced pulmonary hypertension [10].
SinceitsroleindevelopingHFhasnotbeeninvestigatedprevi-
ously, the aim of the present study was to elucidate whether H2S
couldattenuateventriculardysfunctionandarresttheprogression
of HF after MI.
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MATERIALS AND METHODS
Animal care
Male Sprague–Dawley rats weighing 250–300 g were used for
this experiment. The animals were housed under diurnal lighting
conditions and fed standard rat chow and water ad libitum.A l l
animal experiments were performed in accordance with the An-
imalManagementRulesoftheMinistryofHealthofthePeople’s
Republic of China and approved by the Animal Research Ethics
Committee, School of Pharmacy, Fudan University.
Drugs
PAG (propagylglycine) was purchased from Shanghai Intechem
Technology, and sodium hydrosulﬁde (NaHS) was purchased
fromSigmaChemical.Bothdrugsweredissolvedinsalinebefore
intraperitoneal injection.
HF model and treatment protocols
MI was induced by ligation of the left anterior descending coron-
aryarteryapprox.2–3 mmfromitsorigin,asdescribedpreviously
[11]. Brieﬂy, the rats were anaesthetized with 7% chloral hydrate
(3.5 mg/kg, intraperitoneal injection), endotracheally intubated
and mechanically ventilated with room air at a respiratory rate
of 100 breaths/min and a tidal volume of 2.5 ml with a rodent
ventilator (DHX-150). Electrocardiography was recorded in the
anaesthetized animal for a period of 1 min using the Animal
Mﬂab200 ampliﬁer. Under sterile conditions, a left thoracotomy
was performed, and the fourth intercostal space was exposed.
The pericardium was opened, and the heart was removed from
the thoracic cavity. The proximal left anterior descending coron-
aryarterywasligatedwitha6-0atraumaticsuturethatwaspassed
through the superﬁcial layers of the myocardium. Successful lig-
ationofthecoronaryarterywasveriﬁedbythecolourchangeim-
mediately in the ischaemic area (anterior ventricular wall and the
apex) of the heart and MI was conﬁrmed by electrocardiography
(ST-segment elevation was observed). The heart was returned to
the chest cavity, the lungs were reinﬂated and the chest incision
was closed. Sham-operated rats were prepared in the same man-
ner except for the left coronary ligation. After completion of the
surgicalprocedures,ratswereremovedfromtheventilatorandthe
endotracheal tube was removed. Operative mortality was approx.
45% due to acute sudden death within the ﬁrst 48 h after surgery.
ThesizeofMIat48 hthatwemeasuredinthepreliminaryexper-
iments was 37.2+ −3.2% by 1% TTC (2,3,5-triphenyltetrazolium
chloride) as in the previous study [9]. Electrocardiography was
recorded 48 h after the operation. Limb lead was evaluated. The
animals that showed a large Q wave (>0.3 mV) in lead II were
used in subsequent experiments.
Surviving rats from the MI model and sham-operated groups
were randomly assigned to six treatment groups: (i) HF rats
treated with equal volume of vehicle (n=20), (ii) HF rats treated
with NaHS (3.136 mg · kg−1 · day−1)( n=20), (iii) HF rats
treated with PAG (37.5 mg · kg−1 · day−1)( n=20), (iv) sham-
operated rats treated with vehicle (n=5), (v) sham-operated rats
treated with NaHS (3.136 mg · kg−1 · day−1)( n=5) and (vi)
sham-operated rats treated with PAG (37.5 mg · kg−1 · day−1)
(n=5). During the treatment periods, cages were inspected daily
for rats that had died. Treatment was continued for 6 weeks until
haemodynamic measurements and sample collection had taken
place.
Measurements of haemodynamic parameters
At 6 weeks after the operation, 7% chloral hydrate (3.5 mg/kg,
intraperitonealinjection)wasinjected.TheHR(heartrate),LVSP
(left ventricular systolic pressure), LVEDP (left ventricular end-
diastolic pressure), +LVdp/dt (the maximum rate of pressure de-
velopment) and –LVdp/dt (maximum rate of pressure decay over
time) of sham-operated and HF rats with vehicle, NaHS and
PAG treatments were measured by methods described previ-
ously [11]. During chloral hydrate anaesthesia, a cannula with
a heparinized PP10 in PP50 catheter was inserted into the LV
(left ventricle) through the right common carotid artery. The
catheter was connected to a pressure transducer. The pressure
transducer was connected to a Powerlab data recording system
(MFLab 200, AMP 20020830, Image analysis system). The in-
dices of haemodynamic parameters, such as HR, LVSP, LVEDP,
+LVdp/dt and –LVdp/dt, were measured.
Morphological assessment of HF
After completing the measurements of haemodynamic paramet-
ers, the hearts and lungs were extracted for further examination.
Thelung-to-bodyweightratiothatservesasanindexforpulmon-
ary oedema after HF was determined (n=5 per group). Hearts
were carefully dissected by separating the LV (left ventricular
free wall and interventricular septum) from the atria and right
ventricle, followed by immediate freezing in liquid nitrogen and
storage at –80◦C until extraction of total RNA [12]. The LVs
were used for determining mRNA and protein levels.
Analysis of LV ﬁbrosis after MI
Rat heart tissues (n=1 for the sham group, n=3 for each HF
group) were ﬁxed in 4% formalin overnight, dehydrated and
ﬁnally embedded in parafﬁn. The embedded tissues were then
cut into 5 μm slices and stained with the histological stain Picric
Sirius Red, which distinguishes the ﬁbrosis part (red) from non-
ﬁbrosis myocardial tissue (yellow). Images of the sectioned tis-
sues were captured using an image analysis program for ﬁbrosis
size analysis, namely UTHSCSA ImageTool.
Measurement of H2S concentration from plasma
H2Sconcentrationsweremeasuredinplasmatakenafter6 weeks
of treatment (n=5 per group). In brief, plasma from rat
blood was collected and centrifuged prior to the animals be-
ing killed. Subsequently, 75 μl of the plasma sample was
mixed with 250 μl of 1% zinc acetate and 425 μl of distilled
waterina1.5 mlEppendorftube.Subsequently,133 μlof20mM
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N-dimethyl-p-phenylenediamine sulfate was added in 7.2 mM
HCl and 133 μlo f3 0m MF e C l 3 in 1.2 mM HCl, and the reac-
tion mixture was then incubated at room temperature (25◦C) for
10 min. The protein pellet in the reaction mixture was extracted
by adding 250 μl of 10% trichloroacetic acid and centrifugation
at32900 gfor5 min.Theattenuance(D)oftheresultingsolution
at 670 nm was assayed in a 96-well plate and measured using a
spectrophotometer(TECANSystems).Allsampleswereassayed
in duplicate, and the concentrations of each sample were calcu-
lated against a calibration curve using NaHS (3.125–250 μM).
Plasma H2S concentration in μM is presented as previously re-
ported [9,13,14].
Separation of cytosolic protein and mitochondrial
protein
Isolation of mitochondria protein from left ventricular tissue was
performed according to the manufacturer’s protocol (Beyotime,
Nantong, China). The tissues (n=4 per group) were washed
twice with ice-cold PBS, resuspended in lysis buffer (20 mM
Hepes/KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1.0 mM so-
dium EDTA, 1.0 mM sodium EGTA, 1.0 mM dithiothreitol,
0.1 mM PMSF and 250 mM sucrose) and then homogenized by
an autohomogenizer in ice/water. After removing the nuclei and
cell debris by centrifugation at 1000 g for 10 min at 4◦C, the su-
pernatantswerefurthercentrifugedat10000 gfor10 minat4◦C.
The resulting mitochondrial pellets were resuspended in lysis
buffer. The supernatants from the 10000 g centrifugation were
centrifuged once more at 100000 g for 1 h at 4◦C and then col-
lected. The supernatants and mitochondrial fractions were stored
at –80◦C. Proteins from the cytoplasm and mitochondria were
used to measure the leakage of cytochrome c.
Total protein extraction from left ventricular tissue
Frozentissues(n=4pergroup)werecutintosmallpiecesandho-
mogenized in 0.5 ml of RIPA buffer (150 mM NaCl, 1% Nonidet
P40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris/HCl and 2 mM
PMSF, pH 7.4) prior to being transferred into small tubes and ro-
tated at 4◦C overnight. Solubilized proteins were collected after
centrifugation at 10000 g for 30 min. The supernatant was col-
lected and stored at –80◦C. Those whole cell proteins were used
to test the expression of CSE and apoptotic factors such as Bcl-2,
Bax and caspase 3.
Western-blot analysis of proteins in left ventricular
tissue
Theproteinconcentrationofeachsamplewasquantiﬁedusingthe
enhanced BCA (bicinchoninic acid) Protein Assay kit (Beyotime
Biotechnology,Haimen,China).TodetectCSE,Bcl-2,Bax,cyto-
chrome c and caspase 3 protein levels, protein lysates from each
group of rats were separated by SDS/PAGE and electrotrans-
ferred on to a PVDF membrane (Millipore). Polyacrylamide gels
(12%) were used for CSE (43 kDa) and pro-caspase 3 (32 kDa)
protein testing. For Bcl-2 (29 kDa), Bax (21 kDa), cytochrome c
(15 kDa)andcleavedcaspase3(17 kDa)proteinexpression,15%
(w/v) polyacrylamide gels were used. The non-speciﬁc proteins
on membranes were blocked with 5% non-fat dried skimmed
milk powder prepared in TBS+0.1% Tween 20 for 2 h at room
temperature. Immunoblotting was then performed using 2 μg/ml
rabbit anti-rat CSE polyclonal antibody (R&D Systems), rabbit
anti-rat Bcl-2 and Bax polyclonal antibodies (Santa Cruz Bio-
technology), rabbit anti-human caspase 3 polyclonal antibody
(Santa Cruz Biotechnology) and mouse anti-horse cytochrome c
monoclonal antibody (Santa Cruz Biotechnology) respectively.
Membrane blots were washed and incubated with horseradish-
peroxidase-conjugated anti-rabbit IgG antibodies or anti-mouse
IgG antibodies at a 1:10000 dilution (Jackson ImmunoResearch
Laboratories). Immunoreactive proteins were then visualized us-
ing ECL® plus, a Western blotting detection system (Alpha In-
notech).
Total RNA isolation and RT–PCR (reverse
transcription–PCR)
Total RNA from non-infarcted left ventricular tissue (n=4
per group) was extracted using TRIzol® reagent according to
the manufacturer’s instructions. RNA was spectrophotometric-
ally quantiﬁed by measuring the absorbance of samples at
260 nm/280 nm and then re-dissolved in 30–50 μlo fD E P C
(diethyl pyrocarbonate)-treated water (mRNA concentration of
each sample was 50 ng/μl) and stored at –80◦C. Then, 2 μgo f
mRNA was reversed-transcribed to cDNA with a PrimeScriptTM
1stStrandcDNASynthesiskitandstoredat–20◦C.RT–PCRwas
performed in a 0.2 ml tube with a total sample volume of 25 μl
containing 2 μl of tissue cDNA, 1 μlo f5μM per primer mix-
ture,1 μlof2.5 mMperdNTPmixture,1.5 μlof1.5 mMMgCl2,
2.5 μlof10×PCRbufferand1.25 unitsofTaqDNApolymerase.
The gene encoding GAPDH (glyceraldehyde-3-phosphatase de-
hydrogenase) was considered as an internal standard. PCR was
run at 35 cycles for GAPDH, CSE and caspase 3 and at 40 cycles
for Bax and Bcl-2. Reverse transcription action was performed at
50◦C for 30 min. Samples were then heated to 95◦C for another
15 min for the initial PCR activation step. Three-step PCR began
with denaturation at 94◦C for 30 s, followed by 30 s of annealing
for GAPDH, CSE, Bcl-2 and caspase 3 at 56◦C and for Bax at
57◦C and then continued with an extension at 72◦Cf o r1m i n .
A ﬁnal extension was carried out at 72◦C for 15 min. The PCR
productswereseparatedelectrophoreticallyona1.5%agarosegel
andstainedwithethidiumbromide.Theabsorbanceofthebandof
each mRNA was measured by using the Fluor Chem SP system.
Primer preparations were devised in accordance with GenBank®
Nucleotide Sequence Database. The nucleotide sequences of the
primers used in the present study are shown in Table 1.
TUNEL (terminal deoxynucleotidyl transferase-
mediated dUTP nick-end labelling) assay
The TUNEL assay was used to test the apoptosis of cardiomyo-
cytes in rat hearts. The heart tissues (n=1 for sham group and
n=3 for each HF group) were ﬁxed in 4% formalin overnight,
dehydrated and then embedded in parafﬁn. The tissues were cut
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Table 1 Primers was used in the present study
Gene GenBank® accession no. Nucleotide sequence Product size (bp)
CSE AY641456 201
Sense 5 - TCCGATGACCTCAACGAAC -3 
Antisense 5 -CGGTAGCCCAGGATAAATAA-3
Caspase 3 NM012922 102
Sense 5 -CTGGACTGCGGTATTGAG-3 
Antisense 5 -GGGTGCGGTAGAGTAAGC-3
Bcl-2 NM 016993 422
Sense 5 -CGGGAGATCGTGATGAAGT-3 
Antisense 5 -CCACCGAACTCAAAGAAGG-3 
Bax NM007527 579
Sense 5 -GCAGGGAGGATGGCTGGGGAGA-3
Antisense 5 -TCCAGACAAGCAGCCGCTCACG-3 
GAPDH NM017008 578
Sense 5 -TTCAACGGCACAGTCAAGG-3 
Antisense 5 -CGGCATGTCAGATCCACAA-3 
into 7 μm thick slices. The assay was tested by a TdT-FragELTM
DNA Fragmentation Detection kit acquired from Calbiochem,
and the empirical procedure was performed according to the kit’s
protocol.
Morphological change in the myocardium
Ultrastructural apoptosis of cardiomyocytes in our present study
was detected by EM (electron microscopy). Samples were taken
at the peri-infarct site in three rats from each group. Samples
for EM were cut into pieces less than 1 mm3 a n dﬁ x e di n
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4)
for 4 h. Tissues were post-ﬁxed in 1% osmium tetroxide in 1%
K4Fe(CN)6 buffered with 0.1 M sodium cacodylate, dehydrated
through graded concentrations of ethanol and propylene oxide
andsubsequentlyembeddedinEpon812.Ultrathinsectionswere
cut from blocks and mounted on copper grids. Then, the grids
werecounterstainedwithleadcitrateanduranylacetate.Thesec-
tions were observed with a Philips CM 120 electron microscope.
Statistical analysis
Data are expressed as means+ −S.E.M. All data involving mul-
tiple groups were analysed by one-way ANOVA. Differences
between individual groups were analysed using the Student’s
t test. Survival rate was analysed by the Kaplan–Meier analysis
usingthelog-ranktest.AdifferencewithP<0.05wasconsidered
statistically signiﬁcant.
RESULTS
Survival rate
Total mortality during the observation periods from the ﬁrst
to sixth week in rats subjected to coronary ligation was 2/20
NaHS, while vehicle was 5/20 and PAG was 8/20. During the
Figure 1 The Kaplan–Meier survival plot
A survival plot demonstrating a signiﬁcant reduction in overall mortality
in the NaHS-treated group (2/20) compared with vehicle-treated anim-
als (5/20), and the PAG-treated group (8/20) had a higher mortality
rate compared with vehicle-treated animals (P<0.05).
6-week observation period, none of the sham-operated animals
died. The survival rate among NaHS-treated ligated rats (90%)
was signiﬁcantly high compared with the vehicle-treated group
(75%) and the PAG-treated group (60%) (P<0.05). This sig-
niﬁcant difference in survival rate was not due to differences in
infarctsizebecausetheratswererandomlygrouped48 hafterMI
(Figure 1).
Effects on left ventricular haemodynamic
parameters
LVSP in PAG-treated HF rats (107+ −2.2 mmHg; 1 mmHg=
0.133 kPa) was lower compared with vehicle-treated HF rats
(119+ −3.1 mmHg, P<0.05), and it was even lower compared
with NaHS-treated HF rats (132+ −1.8 mmHg, P<0.01). The
LVSP of NaHS-treated HF rats is higher than that of vehicle-
treated HF rats (P<0.05). The LVEDP was increased in PAG-
treated HF rats (18+ −0.9 mmHg) compared with vehicle-treated
HF rats (14+ −0.9 mmHg, P<0.05); it was also higher than that
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Table 2 Haemodynamic parameters of HF and sham rats at the sixth week after the operation (n=5 for
each sham group and n=8 for each HF group)
In model group, *vehicle versus NaHS, P<0.05; †vehicle versus PAG, P<0.05; ‡sham versus model+vehicle,
P<0.05.
Sham Model
Vehicle NaHS PAG Vehicle NaHS PAG
HR (beat/min) 438+ −13 407+ −14 430+ −19 439+ −15 437+ −15 437+ −14
LVSP (mmHg) 137+ −1.3 139+ −1.7 135+ −1.3 119+ −3.1‡ 132+ −1.8* 107+ −2.2†
LVEDP (mmHg) 3.3+ −0.3 3+ −14 + −1.2 14+ −0.9‡ 10+ −0.9* 18+ −0.9†
LV+dp/dt (1000 mmHg/s) 6.6+ −0.2 5.9+ −0.3 6.0+ −0.1 4.4+ −0.5‡ 5.8+ −0.2* 3.2+ −0.2
LV−dp/dt (1000 mmHg/s) 5.4+ −0.2 5.0+ −0.5 5.2+ −0.4 3.5+ −0.1‡ 4.9+ −0.4* 3.1+ −0.2
of NaHS-treated HF group (10+ −0.9 mmHg, P<0.05). The de-
creaseinLV+dp/dt inHFratswassigniﬁcantlyincreasedbyNaHS
treatment (5.8+ −0.2 1000 mmHg/s). The aggravated LV−dp/dt
was also improved in NaHS-treated HF group (4.9+ −0.4 1000
mmHg/s).ThesigniﬁcantchangesofLVSP,LVEDPandLV+ −dP/dt
indicated that H2S could improve cardiac function of post-
infarction HF. The heart rate in HF and sham-operated rats was
notaffectedbytreatmentwithNaHSandPAG(showninTable2).
Furthermore, the results indicate that long-term treatments with
NaHS and PAG could not affect the left ventricular haemody-
namicparametersinsham-operatedrats,althoughitshowedasig-
niﬁcant pharmacological effect in pathological conditions (like
HF).
Effects on pulmonary oedema after 6 weeks
of treatment
Figure 2 illustrates the ratio of lung weight to body weight for
HF and sham-operated rats. Compared with sham rats, the lung-
to-body weight ratio was higher in HF rats, P<0.05. NaHS
treatment signiﬁcantly lowered the lung-to-body weight ratio
in HF rats (6.0+ −0.2 mg/g versus 9.2+ −0.5 mg/g in vehicle HF,
P<0.05), and PAG HF (15.6+ −2.1 mg/g) had a much high ratio
compared with vehicle HF (P<0.05). The result indicates that
H2S attenuates the degree of pulmonary oedema during HF. In
sham groups treated with NaHS, saline and PAG, the ratio was
4.9+ −0.1, 4.3+ −0.6 and 5.4+ −0.1 mg/g respectively and there
was no statistical difference.
Result of analysis for LV ﬁbrosis after MI
Fibrosis size was documented as percentage of ﬁbrosis area
compared with total left ventricular area in representative sec-
tions. The ﬁbrosis size/total area of LV was signiﬁcantly less in
rats subjected to NaHS treatment than in vehicle-injected rats
(12.5+ −0.5% versus 25.7+ −1.2%; P<0.01). However, ﬁbrosis
size was greater (37.3+ −0.9%; P<0.05) in the PAG-treated
animals (Figure 3).
Plasma H2S levels in each group after 6 weeks of
treatment
In the NaHS-treated HF group, plasma H2S concentration was
signiﬁcantly increased to 69.5+ −4.6 μM when compared with
Figure 2 Effect of long-term treatment with NaHS and PAG on
change in lung-to-body weight ratio of HF and sham-operated rats
#NaHS-treated HF group versus vehicle-treated group, P<0.05.
&Vehicle-treated group versus PAG-treated group, P<0.05. *Vehicle-
treated HF group versus vehicle sham group, P<0.01.
Figure 3 Myocardial ﬁbrosis size change in vehicle-, NaHS- and
PAG-treated animals
#NaHS-treated HF versus vehicle-treated HF, P<0.05. &Vehicle-treated
HF group versus PAG-treated HF group, P<0.05. *Vehicle-treated HF
versus vehicle sham, P<0.001.
PAG-treated HF group whose plasma H2S concentration
was 45.8+ −1.1 μM, P<0.01, n=8. The concentration in
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Figure 4 Effect of long-term treatment with 3.136 mg/kg NaHS
and 37.5 mg/kg PAG on change in plasma H2S concentration of
HF and sham-operated rats
#NaHS-treated HF group versus vehicle-treated group, P<0.05.
&Vehicle-treated group versus PAG-treated group, P<0.05. *Vehicle-
treated HF group versus sham group, P<0.05.
saline-treated HF group was 53.3+ −2.7 μM, P<0.05,
compared with the other two HF groups. In sham-operated
groups, however, the plasma H2S level of rats was ob-
served as follows: PAG+sham (62.1+ −5.7 μM), NaHS+sham
(69.9+ −1.5 μM), saline+sham (65.1+ −1.5 μM). They were all
slightly higher than their model groups, but it had no statistical
signiﬁcance (Figure 4). Combining the results of survival rate,
heart function, lung-to-body weight ratio and plasma H2S
concentration, it was determined that NaHS and PAG could
not change the physiological function and plasma H2Sl e v e li n
normal rats; therefore, these two sham groups were not included
in the subsequent studies.
Measurement of protein level in left ventricular
tissue
Western blotting was utilized to detect the protein levels of
total CSE and Bcl-2, Bax, cytochrome c, pro- and cleaved
caspase 3. The CSE protein content in the NaHS-treated HF
group (0.66+ −0.04) was higher than vehicle-treated HF group
(0.51+ −0.03) with a statistical signiﬁcance of P<0.05. PAG-
treated HF group showed a decreased CSE protein expression
(0.36+ −0.02, P<0.05) when compared with vehicle-treated HF
group. This showed that NaHS could stimulate the expression of
CSE in LV after MI. Bcl-2 protein content in the NaHS-treated
HFgroup(1.64+ −0.09)washigherthaninthevehicle-treatedHF
group (1.12+ −0.12, P<0.05), which was also higher than in the
PAG-treated HF group (0.64+ −0.04, P<0.05). The Bax protein
contentintheNaHS-treatedHFgroup(0.61+ −0.12)wasthelow-
est among the vehicle-treated HF group (0.93+ −0.06; P<0.05)
andthePAG-treatedHFgroup(1.44+ −0.18;P<0.05)(Figure5).
The ratio of mitochondria cytochrome c and the cytoplasm cyto-
chrome c indicated that the NaHS-treated group had low leak-
age of cytochrome c from the mitochondria to the cytoplasm
Figure 5 Cardiac protein expression in LV using the Western-blot method
(A) SDS/PAGE analysis shows CSE, Bcl-2 and Bax protein levels in LV of rats after a 6 week treatment, (B) change of CSE
protein expression, (C) change of Bcl-2 protein expression and (D) change of Bax protein expression. #NaHS-treated
HF versus vehicle-treated HF group, P<0.05. &Vehicle-treated HF group versus PAG-treated HF group, P<0.05.
*Vehicle-treated HF versus vehicle sham group, P<0.05.
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Figure 6 Leakage of cytochrome c protein from the mitochondria
to the cytoplasm using the Western-blot method
*Vehicle-treated HF versus vehicle sham group, P<0.05.
#NaHS-treated HF versus vehicle-treated HF group, P<0.05. &Vehicle-
treated HF group versus PAG-treated HF group, P<0.05.
Figure 7 Activation of caspase 3 from pro-caspase 3 (32 kDa) to
cleaved caspase 3 (17 kDa) using the Western-blot method
*Vehicle-treated HF versus vehicle sham group, P<0.05.
#NaHS-treated HF versus vehicle-treated HF group, P<0.05. &Vehicle-
treated HF group versus PAG-treated HF group, P<0.05. KD, kDa.
compared with the vehicle-treated group (P<0.05), which also
had lower leakage than the PAG-treated group (P<0.05; Fig-
ure6).Theresultsalsoshowedasigniﬁcantincreaseinactivation
of caspase 3 in HF hearts by comparing the intensities of cleaved
with uncleaved caspase 3 fragments (Figure 7). The cleavage of
caspase 3 in normal hearts was negligible (3.25+ −2.1%) com-
pared with 31.8+ −2.5% in the vehicle-treated HF group. And
NaHS treatment lowered the activation of caspase 3 in failing
hearts (20.1+ −2.1%), whereas PAG increased the activation to
43+ −2.9% (P<0.05, versus vehicle-treated HF group).
Measurement of gene expression in ventricular
myocardium
To further verify the changes after post-infarction HF, the gene
expression of CSE and Bcl-2, Bax and caspase 3 mRNA were
assayed by RT–PCR (Figure 8). In the model group, CSE
gene expression was signiﬁcantly higher in NaHS-treated HF
group (0.94+ −0.03) when compared with the vehicle-treated
HF group (0.72+ −0.03; P<0.05). The PAG-treated HF group
(0.52+ −0.01) showed lower CSE gene expression than the
vehicle-treated HF groups (P<0.05). The expression of pro-
apoptotic genes such as Bax and caspase 3 were found to be
lower after treatment with NaHS when compared with treatment
with vehicle (P<0.05). However, Bcl-2 gene expression was
remarkably suppressed after treatment with PAG (1.25+ −0.31)
compared with treatment with vehicle (1.75+ −0.51; P<0.05).
Furthermore,treatmentofNaHScouldincreasetheexpressionof
the Bcl-2 gene (2.28+ −0.22) compared with the vehicle-treated
group. Those results correlate with the observation of protein
changes in the same treatment groups.
Result of the TUNEL assay
The results were detected through a light microscope; a dark
brown DAB (diaminobenzidine) signal indicated positive stain-
ing, while shades of blue-green to greenish tan signiﬁed a non-
reactive cell. Since the 3 -OH ends of DNA fragments generated
by apoptosis were concentrated within the nuclei and apoptotic
bodies, morphology as well as DAB staining could be used to
interpret FragELTM results. Non-apoptotic cells did not incorpor-
ate signiﬁcant amounts of labelled nucleotide, since they lacked
an excess of 3 -OH ends and should be dominantly rounded and
appear counterstained with Methyl Green. This further explained
that more brown nuclei represented more apoptotic cells in heart
tissues. In Figure 9(A), a few of the brown nuclei are found in the
sham group heart, while the number of brown nuclei increased
signiﬁcantly in model groups. The NaHS treatment could atten-
uate the number of apoptotic cells. By contrast, PAG increased
cardiomyocyte apoptosis. Cells with brown nuclei and total nuc-
lei in the peri-infarcted area for ﬁve visual ﬁelds in a section
were counted, and there were four sections for each group. The
ratio for the number of brown nuclei in the total nuclei was also
calculated. The result had statistical signiﬁcance and is shown in
Figure 9(B).
Morphological change in the myocardium after
6 weeks of treatment
After 6 weeks treatment, the rat heart sections were examined by
EM. There was no evidence of apoptosis in the sham-operated
rat. A normal cardiomyocyte is shown in Figure 10. Finely
granular chromatin was present. Mitochondria showed regular
cristae. A normal arrangement of sarcomeres was also evident.
In the vehicle-treated model group, the consistent presence of
mitochondrial derangements was examined. Mitochondria ap-
peared to be swollen with disorganized cristae and formation of
wrinkled bodies. Loss of normal striations and disorganization
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Figure 8 Cardiac gene expression in LV using the RT–PCR method
(A) Ethidium bromide–agarose gel showing CSE, Bcl-2, Bax and caspase 3 mRNA levels in LV after a 6-week treatment.
(B) Detecting CSE gene expression. (C) Detecting Bcl-2 gene expression. (D) Detecting Bax gene expression. (E) Detecting
Caspase 3 gene expression. #NaHS-treated HF versus vehicle-treated HF, P<0.05. &Vehicle-treated HF versus PAG-treated
HF, P<0.05. *Vehicle-treated HF versus vehicle sham, P<0.05.
ofsarcomereswerealsofound,andtheshapeofthenucleiwasab-
normal.However,theNaHS-treatedgrouphadslightswollenmi-
tochondria, disorganized cristae and myoﬁbrillar derangements.
The PAG-treated group showed severe mitochondrial derange-
ment and myoﬁbrillar derangements, and nuclei condensation
was apparent.
DISCUSSION
H2S has been studied intensively in recent years; it is synthesized
endogenously in various mammalian tissues by two pyridoxal-
5 -phosphate-dependent enzymes responsible for metabolizing
L-cysteine: CBS (cystathionine β-synthase) and CSE. CSE is
am a j o rH 2S-producing enzyme in the cardiovascular system.
A study has highlighted protective effects of H2S on cardiac
myocyte injury during isoprenaline-induced MI [15]. Similarly,
NaHS was observed to limit the size of infarction induced by left
coronary artery ligation. In addition, NaHS also has been shown
to protect cultured myocardial cells against hypoxia-induced cell
death [8].
The recent discovery of the novel effects of H2S on physiolo-
gical functions such as vasodilation [16] and neuromodulation
[17,18] has suggested possible roles for this gas in cardiovascu-
lar and neurological diseases. Moreover, H2S also plays a key
role in the pathophysiology of endotoxin, septic and haemor-
rhagic shock [13], vasorelaxation [19], inﬂammation [14,20] and
cardiac function in rats [21].
In the present study, NaHS was used as an H2S donor, which
was dissolved in water; HS− is released and forms H2S with H+.
This provides a solution of H2S at a concentration that is approx.
33% of the original concentration of NaHS [22]. We found that
long-term treatment with NaHS in the model group promoted a
signiﬁcantincreaseintheH2Splasmalevelswhencomparedwith
the vehicle group and PAG group. This observation corresponds
to the up-regulation of the expression of CSE mRNA and protein
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Figure 9 TUNEL analysis for apoptosis cells
  (white) show normal blue nucleus;   (black) indicate apoptotic nucleus in brown. *Vehicle-treated HF versus vehicle
sham, P<0.05. #NaHS-treated HF versus vehicle-treated HF, P<0.05. &Vehicle-treated HF group versus PAG-treated HF
group, P<0.05.
in myocardial tissues. While we noted that both NaHS and PAG
affected little the concentration of plasma H2S for sham groups,
thisledustohypothesizethat,underphysiologicalconditions,the
H2S level in plasma may keep its balance by its autoregulation.
The haemodynamic measurements were improved in the
NaHS-treated HF group compared with the vehicle and PAG
HF groups by increasing LV+ −dp/dt and LVSP, while decreasing
LVEDP. These parameters indicate that the decrease in myocar-
dial function was improved in the NaHS-treated HF rats. Thus
the increase in survival rate is associated with improvement
of the haemodynamic function of rats with coronary artery liga-
tion. We also found that NaHS decreased the ﬁbrosis size com-
pared with the vehicle HF group, and PAG treatment enlarged
the size. All these show the beneﬁcial long-term effects of H2S
on the haemodynamic parameters of the pathophysiological
changes in developing HF.
Heart rate in rats with coronary artery ligation and sham rats
was not affected by treatment. This ﬁnding is in agreement with
other studies showing that the heart rate remained essentially
unchanged after completing the study of the post-infarction HF
rats[23,24].Inviewoftheunchangedheartrateafterthecoronary
artery ligation, it appears that the maintenance of high output
status at early stages relied on the Frank–Starling reserve and the
intact contractile function [24].
The decrease in LV+ −dp/dt, LVSP and the increased LVEDP
indicatethepresenceofLVdysfunctionindevelopingHFgroups.
Although the permanent occlusion model for HF will have some
limitations such as high risk of operation and high mortality in
the acute period compared with the adriamycin or isoprenaline
model, it is still in common usage in long-term research today
[25].
Manyheartdiseasessuchasmyocardialischaemia/reperfusion
injury and MI result in the robust appearance of cardiac myo-
cyte apoptosis, which contributes to infarct size and long-term
ventricular dysfunction [26–28]. Rescue from apoptotic cell
death through the interference of the central programmed death
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Figure 10 Ultrastructure changes in the peri-infarct area of rat
heart with EM (×20000)
(a) This Figure shows low magniﬁcation for each group; (b) this Figure
shows higher magniﬁcation of the area for each group.   (white) shows
normal mitochondrial;   (black) indicates swelling mitochondria and
some mitochondria with ruptured outer membrane. In the sham group,
mitochondria show regular cristae. Normal arrangement of sarcomeres
is also evident. In the vehicle-treated model group, mitochondrial de-
rangements were always present. Mitochondria appeared swollen, with
disorganized cristae and formation of wrinkled bodies, loss of normal
striations and disorganization of sarcomeres were also found, and
the nuclei shape was abnormal. While the NaHS-treated group had
mitochondria slightly swollen, disorganized cristae and myoﬁbrillar de-
rangements, the PAG-treated group showed severe mitochondrial de-
rangement and myoﬁbrillar derangements, and nuclei condensation is
apparent.
pathways, suchas theknockout of thepro-apoptotic gene or loss-
of-function mutation in the death receptor, consistently reduced
infarct size after ischaemia/reperfusion injury by 50–60% [29]
and may attenuate ventricular dysfunction, which conﬁrms the
importance of apoptosis in these models. Severity of cardiomyo-
pathy after MI, ischaemia/reperfusion injury or aortic constric-
tion is also reduced by inhibition of cardiac myocyte apoptosis
[30,31]. It may also do the same to HF after MI. Some mouse
models demonstrate that cardiac myocyte apoptosis itself can
directly cause dilated cardiomyopathy and is sufﬁcient to result
in decreased survival [32]. Hence, the maintenance of cardiac
myocyte numbers is critical to the overall preservation of both
structural integrity and function of the heart. Similarly, pharma-
cological and transgenic studies in animal models indicate that
theinhibitionofcardiacmyocyteapoptosisappearstoameliorate
the impact of MI and thus arrests the progression to HF.
It is known that apoptosis is mediated by two inter-connected
pathways [33]. The extrinsic or death receptor pathway transmit-
ted death signals from relatively specialized ligands such as Fas
ligand or TNFα (tumour necrosis factor-α). In contrast, the more
ancient intrinsic or mitochondrial/ER (endoplasmic reticulum)
pathway transducts a wide spectrum of death signals that origin-
ate both outside and inside the cell. These include deﬁciency in
nutrients/survival factors/oxygen, oxidative stress, physical and
chemical toxins (radiation and drugs), DNA damage and misfol-
ded proteins. Stimulation of these pathways triggers the translo-
cation of death-promoting proteins (e.g. cytochrome c) from the
mitochondriatothecytoplasm[34]andtheactivationofaclassof
cysteine proteases called caspases. Caspases, in turn, bring about
apoptotic death. In a study by Lefer and colleagues, it was re-
ported that the H2S attenuates myocardial ischaemia/reperfusion
injury by preservation of mitochondrial function [35]. In a differ-
entstudy,itwasreportedthatmitochondrialchangesareprevalent
in apoptosis of the myocardium [36]. Moreover, myoﬁbrillar de-
rangements are obviously peculiar to apoptotic cardiomyocytes,
in keeping with the ﬁnding of caspase 3-dependent myoﬁbrillar
lysis. Therefore the morphological observation of apoptosis in
cardiomyocytes was performed by EM in the present study, and
the result showed that H2S ameliorated mitochondrial derange-
ments, such as swelling, disorganized cristae, loss of normal
striations and attenuation of myoﬁbrillar disorganization. The
TUNEL test also showed that H2S decreased the number of ap-
optotic cardiomyocytes.
The anti-apoptotic factor Bcl-2 and pro-apoptotic factors such
as Bax, caspase 3 and cytochrome c i nt h eL Vw e r et e s t e d .T h e
results showed that H2S could increase the mRNA and protein
expression of Bcl-2, decrease the mRNA and protein expres-
sion of Bax and caspase 3 and lower the mitochondrial cyto-
chrome c release to the cytoplasm. In early apoptotic signalling,
the anti-apoptotic Bcl-2 and pro-apoptotic Bax are in opposi-
tion. A shift in favour of the pro-apoptotic proteins subsequently
results in increased mitochondrial pore permeability, releasing
cytochrome c and apoptosis-inducing factor, which could activ-
ate caspase 3 (32 kDa) into a small fragment (17 kDa), which is
the active form of caspase 3 and facilitates DNA fragmentation
[37]. On cleavage of terminal caspases, such as caspase 3, cell
death is generally thought to be inevitable. In our present study,
levels of early mediators of apoptotic signalling proteins, such as
Bcl-2 and Bax, showed signiﬁcant differences in groups treated
with NaHS and PAG. The downstream effectors like caspase
3 were signiﬁcantly reduced in the NaHS-treated model group,
and H2S could also reduce mitochondria cytochrome c release.
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However, it is important to note that those lines of evidence,
such as the so-called apoptosis-related factors and TUNEL of
DNA fragmentation for apoptosis in cardiomyocytes, are mostly
indirect, and EM has been proposed to be the preferred direct
technique. In sum, H2S could inhibit apoptosis of cardiac myo-
cytes through the mitochondrial pathway to improve the survival
andventriculardysfunctioninthedevelopingHFmodel.Wepro-
pose that H2S could be a valuable pharmacological target for HF
therapy.
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